AAD 2026Abstract 72433
Characterization of the IHS4 Response to Lutikizumab Treatment in Biologic-Naïve Patients With Moderate-to-Severe Hidradenitis Suppurativa (HS)
Alhusayen R, Zouboulis CC, Lima H, Martorell A, Kirby B, Hamzavi IH, Sawicki KT, Gamelli A, He R, Akbari M, Kimball AB
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Hidradenitis suppurativa
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.394 · Not in PubMed: details from Crossref